A crash for the markets - a crash for biotechs ? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A crash for the markets - a crash for biotechs ?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nathan L. who wrote (12)	12/8/1996 8:09:00 PM
From: xray	of 74

Some early stage companies may already be undervalued. Tell me whether nortran.com is only worth a current market cap of about US$ 10 million. Perhaps a downturn will make investors look just a little closer at their investments. Market caps should, in some way, be connected to product market potential and development risk, obviously. Unfortunately, in many small cap biotechs, it is not, thus the downward potential of their prices. Some biotechs/pharmaceuticals are already undervalued.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next